Inhibition of Dipeptidyl Peptidase-4 by Vildagliptin During Glucagon-Like Peptide 1 Infusion Increases Liver Glucose Uptake in the Conscious Dog

OBJECTIVE—This study investigated the acute effects of treatment with vildagliptin on dipeptidyl peptidase-4 (DPP-4) activity, glucagon-like peptide 1 (GLP-1) concentration, pancreatic hormone levels, and glucose metabolism. The primary aims were to determine the effects of DPP-4 inhibition on GLP-1...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Edgerton, Dale S., Johnson, Kathryn M.S., Neal, Doss W., Scott, Melanie, Hobbs, Charles H., Zhang, Xia, Duttaroy, Alokesh, Cherrington, Alan D.
Formato: Artigo
Idioma:Inglês
Publicado em: American Diabetes Association 2009
Assuntos:
Pharmacology & Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2606880/
https://ncbi.nlm.nih.gov/pubmed/18840785
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db08-0515
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados